Evaluation of genetic risk score models in the presence of interaction and linkage disequilibrium
暂无分享,去创建一个
[1] Benjamin Yakir,et al. Linkage disequilibrium patterns of the human genome across populations. , 2003, Human molecular genetics.
[2] Andreas Ziegler,et al. Evaluating diagnostic accuracy of genetic profiles in affected offspring families , 2010, Statistics in medicine.
[3] R. D'Agostino,et al. Genotype score in addition to common risk factors for prediction of type 2 diabetes. , 2008, The New England journal of medicine.
[4] Paul M. Ridker,et al. Association Between a Literature-Based Genetic Risk Score and Cardiovascular Events in Women , 2010 .
[5] Marylyn D. Ritchie,et al. The success of pharmacogenomics in moving genetic association studies from bench to bedside: study design and implementation of precision medicine in the post-GWAS era , 2012, Human Genetics.
[6] Ting Hu,et al. Characterizing genetic interactions in human disease association studies using statistical epistasis networks , 2011, BMC Bioinformatics.
[7] Xin Wang,et al. SNP interaction detection with Random Forests in high-dimensional genetic data , 2012, BMC Bioinformatics.
[8] Jiang Gui,et al. A computationally efficient hypothesis testing method for epistasis analysis using multifactor dimensionality reduction , 2009, Genetic epidemiology.
[9] Teri A Manolio,et al. Genomewide association studies and assessment of the risk of disease. , 2010, The New England journal of medicine.
[10] H. Cordell. Detecting gene–gene interactions that underlie human diseases , 2009, Nature Reviews Genetics.
[11] W. G. Hill,et al. Heritability in the genomics era — concepts and misconceptions , 2008, Nature Reviews Genetics.
[12] Nancy R Cook,et al. Association between a literature-based genetic risk score and cardiovascular events in women. , 2010, JAMA.
[13] S. Humphries,et al. Utility of genetic and non-genetic risk factors in prediction of type 2 diabetes: Whitehall II prospective cohort study , 2010, BMJ : British Medical Journal.
[14] R. Altman,et al. Estimation of the warfarin dose with clinical and pharmacogenetic data. , 2009, The New England journal of medicine.
[15] K. Lunetta. Genetic Association Studies , 2008, Circulation.
[16] T. Reich,et al. A perspective on epistasis: limits of models displaying no main effect. , 2002, American journal of human genetics.
[17] M. McCarthy,et al. Genome-wide association studies for complex traits: consensus, uncertainty and challenges , 2008, Nature Reviews Genetics.
[18] Nilanjan Chatterjee,et al. Estimation of effect size distribution from genome-wide association studies and implications for future discoveries , 2010, Nature Genetics.
[19] Alison A. Motsinger-Reif,et al. A comparison of internal validation techniques for multifactor dimensionality reduction , 2010, BMC Bioinformatics.
[20] A. Motsinger-Reif,et al. A New Explained-Variance Based Genetic Risk Score for Predictive Modeling of Disease Risk , 2012, Statistical applications in genetics and molecular biology.
[21] H. Cordell. Epistasis: what it means, what it doesn't mean, and statistical methods to detect it in humans. , 2002, Human molecular genetics.
[22] J. Ross,et al. Pharmacogenomic predictor of sensitivity to preoperative chemotherapy with paclitaxel and fluorouracil, doxorubicin, and cyclophosphamide in breast cancer. , 2006, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.
[23] Chad C. Brown,et al. Loss of Power in Two‐Stage Residual‐Outcome Regression Analysis in Genetic Association Studies , 2012, Genetic epidemiology.